SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer) — SEC 8-K Filing
Supernus Pharmaceuticals→Navitor Pharmaceuticals
Apr 7, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Tracking 108 divestiture M&A deals. Browse divestiture transactions across all sectors and states.
Supernus Pharmaceuticals→Navitor Pharmaceuticals
Apr 7, 2026
Allen Investment Partners→Greyhound station property at 2910 N. Arthur Ashe Blvd
Apr 7, 2026
Adapti→Levelution Sports Agency
Apr 6, 2026
Aquila Commercial→Campus at Arboretum
Apr 3, 2026
TVS Venu Group→PGIM India Asset Management
Apr 3, 2026
Veolia→Enviri Clean Earth business
Apr 3, 2026
Woodside→Northwest Houston office campus
Apr 2, 2026
Ardent Health→NextCare Urgent Care clinics in New Mexico
Apr 2, 2026
UConn Health→Solnit Hospital
Apr 2, 2026
Falcone Group→Miami Worldcenter retail district
Apr 2, 2026
Samsung Biologics→GSK manufacturing facility
Apr 2, 2026
Related Ross→Fiserv
Apr 2, 2026
Huntsville Hospital Health System→Crestwood Medical Center
Apr 2, 2026
Legacy sensor technology business
Apr 2, 2026
Commercial Vehicle Group
Apr 2, 2026
Remgro→Mediclinic Southern Africa
Apr 2, 2026
Innovative Solutions & Support→Honeywell International
Apr 2, 2026
Four Corners Property Trust→BluePearl Pet Hospital Property
Apr 1, 2026
Hope Bancorp→SMBC Manubank
Apr 1, 2026
TransUnion→RealNetworks Mobile Division
Apr 1, 2026